Search Results - "Ang PCS"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

    Authors: Khor CC Ong WS Lim EH et al.

    Source: NPJ breast cancer [NPJ Breast Cancer] 2026 Mar 20; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 20.

    Publication Type: Journal Article

    Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.

    Authors: Khor CC Winter S Sutiman N et al.

    Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Mar; Vol. 113 (3), pp. 712-723. Date of Electronic Publication: 2023 Jan 31.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.

    Authors: Dai MS Feng YH Chen SW et al.

    Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Oct; Vol. 189 (3), pp. 665-676. Date of Electronic Publication: 2021 Sep 23.

    Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

    Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.

    Authors: Moy B Oliveira M Saura C et al.

    Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jul; Vol. 188 (2), pp. 449-458. Date of Electronic Publication: 2021 Apr 28.

    Publication Type: Journal Article; Randomized Controlled Trial

    Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.

    Authors: Sutiman N Lim JSL Muerdter TE et al.

    Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2016 Oct; Vol. 55 (10), pp. 1239-1250.

    Publication Type: Journal Article

    Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

    PDF Full Text
    Save to List
  6. 6

    Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.

    Authors: Lal S Sutiman N Ooi LL et al.

    Source: The pharmacogenomics journal [Pharmacogenomics J] 2017 Jul; Vol. 17 (4), pp. 337-343. Date of Electronic Publication: 2016 Mar 15.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE

    Save to List
  7. 7

    Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors.

    Authors: Lim WT Tan EH Toh CK et al.

    Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2010 Feb; Vol. 21 (2), pp. 382-388. Date of Electronic Publication: 2009 Jul 24.

    Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

    Save to List

Search Tools: